Metformin in women with cardiac syndrome X: a randomised double blind placebo controlled trial
| ISRCTN | ISRCTN28863939 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN28863939 |
| Secondary identifying numbers | PG/99124 |
- Submission date
- 31/01/2002
- Registration date
- 31/01/2002
- Last edited
- 10/09/2007
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr N Sattar
Scientific
Scientific
University Department of Pathological Biochemistry
Glasgow Royal Infirmary
Glasgow
G31 2ER
United Kingdom
| Phone | +44 (0)141 211 4312 |
|---|---|
| nsattar@clinmed.gla.ac.uk |
Study information
| Study design | Randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Hospital |
| Study type | Treatment |
| Scientific title | |
| Study objectives | Not provided at time of registration |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Cardiac syndrome X |
| Intervention | 1. Metformin 500 mg twice daily (BD) 2. Matching placebo 1 tab BD Both treatments will continue for 8 weeks. |
| Intervention type | Drug |
| Pharmaceutical study type(s) | |
| Phase | Not Specified |
| Drug / device / biological / vaccine name(s) | Metformin |
| Primary outcome measure | Not provided at time of registration |
| Secondary outcome measures | Not provided at time of registration |
| Overall study start date | 01/01/1997 |
| Completion date | 01/01/2001 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | Female |
| Target number of participants | Not provided at time of registration |
| Key inclusion criteria | Women, post menopausal but less than 70 years with Cardiac Syndrome X (definition angina/positive exercise test/normal coronary arteriogram) |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 01/01/1997 |
| Date of final enrolment | 01/01/2001 |
Locations
Countries of recruitment
- Scotland
- United Kingdom
Study participating centre
University Department of Pathological Biochemistry
Glasgow
G31 2ER
United Kingdom
G31 2ER
United Kingdom
Sponsor information
British Heart Foundation
Charity
Charity
14 Fitzhardinge Street
London
W1H 6DH
United Kingdom
| Phone | +44 (0)20 7935 0185 |
|---|---|
| research@bhf.org.uk | |
"ROR" |
https://ror.org/02wdwnk04 |
Funders
Funder type
Charity
British Heart Foundation (UK)
Private sector organisation / Trusts, charities, foundations (both public and private)
Private sector organisation / Trusts, charities, foundations (both public and private)
- Alternative name(s)
- the_bhf, The British Heart Foundation, BHF
- Location
- United Kingdom
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | Results | 05/09/2006 | Yes | No |
